Biogened S.A. (WSE:BGD)

Biogened Revenue

Biogened had revenue of 28.30M PLN in the quarter ending March 31, 2026, a decrease of -13.85%. This brings the company's revenue in the last twelve months to 109.49M, down -4.12% year-over-year. In the year 2025, Biogened had annual revenue of 113.11M with 1.96% growth.

• Revenue (ttm): 109.49M
• Revenue Growth: -4.12%
• P/S Ratio: 0.42
• Revenue / Employee: 595.07K
• Employees: 184
• Market Cap: 45.69M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	113.11M	2.18M	1.96%
Dec 31, 2024	110.93M	15.37M	16.09%
Dec 31, 2023	95.56M	15.94M	20.02%
Dec 31, 2022	79.62M	14.30M	21.89%
Dec 31, 2021	65.32M	16.99M	35.15%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error